Bret Jensen
Bret Jensen is the lead equities analyst with Investors Alley. He's the editor of their newsletters including The Growth Stock Advisor and Biotech Gems.
Bret Jensen's Latest Posts
Biotech Is Back: Why The 15% Rally Is For Real
After falling over 40% in six months, the biotech sector has soared 15% in just the last two weeks. The sector remains oversold, creating very appealing entry points. These four companies are Bret Jensen’s favorites to continue the rally. After spending over six months deep in the doldrums, and in the deepest and longest bear […]
3 Undervalued Stocks To Buy For Under $10
Buy shares in these three companies about to rally from their undervalued lows. Trading for under $10 each, these stocks are much too cheap for their growth prospects. In my last column I noted that I am becoming increasingly cautious on equities after the recent rally in the market. My cash allocation is up to […]
3 Undervalued Biotech Stocks With Upcoming Catalysts
New drug approvals and the rollout of just-commercialized products will be the catalysts that send these undervalued stocks rallying. Negative sentiment has dropped their prices so low that any rally from these prices could return investors explosive gains. Despite four straight weeks of gains in the S&P 500, the biotech sector continues to be mired […]
3 Post-Selloff Bargains To Buy In Biotech
The biotech sector is offering valuations so cheap right now that in some cases you can buy shares in a company for less than the cash they have in the bank. Sentiment won’t stay this low forever, and when it turns these three stocks will rally back to their former highs. It has been an […]
Buy These 4 Undervalued Biotech Stocks On Sale Today
Valuations this cheap haven’t been available in biotech since 2011, and buying any of these four stocks right now could be one of your best investing decisions of 2016. Don’t miss out on the chance to buy these undervalued biotechs that already have commercialized products for what is almost a 50% discount. It has been […]
3 Stocks Unaffected By The Freefalling Global Economy
If watching the market spiral further down is having you reach for the antacids, take refuge in the safety of stocks that only do business in the States. Trading for great values and unaffected by the strong dollar or overseas turmoil, these three all-American stocks make great portfolio additions. To say that the global economic […]
4 Undervalued Bargains To Buy In Biotech
Editor’s Note: This article discusses opportunities in the biotech space, which is often populated with small and micro cap stocks. Sporting their cheapest valuations since 2011 and superior long-term values over the rest of the market, now is the time to shop the bargain bin in biotech. See Bret Jensen’s top four picks to start […]
